[Okinawa Churaumi Aquarium] Development of a New Treatment Method for Fish Parasites Applying 'Shark Artificial Amniotic Fluid'
Key facts
- [Okinawa Churaumi Aquarium] Development of a New Treatment Method for Fish Parasites Applying 'Shark Artificial Amniotic Fluid'
- Okinawa Churaumi Aquarium has developed a new treatment method for fish parasites by applying 'artificial uterus' technology for sharks, which has been under research since 2017. This method, using a mixture of seawater, freshwater, and urea, is safe for fish sensitive to freshwater baths and was patented on May 20, 2026.
- Source: PR Times
- Date: June 9, 2026
Direct answer
Okinawa Churaumi Aquarium has developed a new treatment method for fish parasites by applying 'artificial uterus' technology for sharks, which has been under research since 2017. This method, using a mixture of seawater, freshwater, and urea, is safe for fish sensitive to freshwater baths and was patented on May 20, 2026.
- Citation
- [Okinawa Churaumi Aquarium] Development of a New Treatment Method for Fish Parasites Applying 'Shark Artificial Amniotic Fluid' (June 9, 2026), PR Times
- Source
- PR Times
- Date
- June 9, 2026
Okinawa Churaumi Aquarium has developed a new treatment method for fish parasites by applying 'artificial uterus' technology for sharks, which has been under research since 2017. This method, using a mixture of seawater, freshwater, and urea, is safe for fish sensitive to freshwater baths and was patented on May 20, 2026.
📋 Article Processing Timeline
- 📰 Published: June 9, 2026 at 22:00
- 🔍 Collected: June 9, 2026 at 13:21
- 🤖 AI Analyzed: June 9, 2026 at 14:15 (54 min after Collected)
■ Background of the Research
Monogeneans are parasites of several millimeters in size that attach to the skin and gills of fish, and a heavy infestation significantly affects the host's health. In aquariums, a method called 'freshwater bath,' where the infected fish are soaked in freshwater for a short time, is widely used to remove these parasites. However, this method cannot be applied to fish that are extremely sensitive to freshwater environments, such as some agnathans (hagfish) and elasmobranchs (sharks and rays). Aquariums that house diverse fish species needed a treatment applicable to fish for which freshwater baths cannot be used.
■ Development History
As part of the 'shark artificial uterus' development, the aquarium developed a solution (artificial amniotic fluid) in 2021 for raising shark fetuses outside the mother's body. This solution is a mixture of freshwater, seawater, and urea in specific ratios, and it has chemical properties similar to shark plasma. Subsequent research suggested that this solution could be effective not only for raising shark fetuses but also for eliminating parasitic monogeneans.
By adjusting the mixing ratios of freshwater, seawater, and urea, the aquarium successfully developed a solution (urea water) that can safely and efficiently eliminate monogeneans while remaining safe for the host agnathans and elasmobranchs.
■ Overview of the Parasite Removal Method
Fish infected with parasitic diseases are soaked for a short time (about 5 minutes) in a solution of mixed seawater, freshwater, and urea (urea water) to eliminate the monogeneans attached to the body surface.
This technology has been patented as a safe method for removing parasites in agnathans and elasmobranchs where freshwater baths cannot be applied.
- Invention Title: Method for removing epidermal monogenean parasites
- Applicant: Okinawa Churashima Foundation
- Date of Registration: May 20, 2026
- Patent Number: Patent No. 7866821
This technology is already being used to treat hagfish at the aquarium. The aquarium will continue to develop new husbandry techniques through research to realize better welfare for captive animals.
FAQ
What are the features of the parasite control technology developed by the Okinawa Churaumi Aquarium?
This technology applies artificial amniotic fluid techniques developed in 'shark artificial uterus' research, using a solution of seawater, freshwater, and urea to safely remove parasites from fish species that cannot be treated with freshwater baths.
What types of fish is this control method suitable for?
It is particularly effective for jawless fish (such as hagfish) and cartilaginous fish (such as sharks and rays) that are sensitive to freshwater environments.
What is the patent information for this technology?
The invention is named 'Method for Removing Monogeneans from the Skin Surface,' with Patent Number 7866821, registered on May 20, 2026.
Can you explain the specific procedure for the control method?
The infected fish are immersed in a solution of seawater, freshwater, and urea (urea water) for about 5 minutes to remove monogeneans from their skin surface.
Is this technology already in practical use?
Yes, it has already been used at the Okinawa Churaumi Aquarium to treat a captive purple hagfish.